Skip to main content
OpenTrials
Completed

NCT Number: NCT02639429

Cervical Ripening for Obese Women: A Randomized, Comparative Effectiveness Trial

Obese pregnant women (BMI ≥ 30 kg/m2) are more likely than their normal-weight counterparts to require induction of labor because of increased rates of obstetric complications including pregnancy related hypertensive disorders, diabetes, and prolonged gestations. Several studies have shown that obese women experience increased labor duration and oxytocin needs when compared to normal-weight women. This in turn results in increased rates for unplanned cesarean delivery (CD) as a result of failed induction of labor (IOL), arrest disorders and non-reassuring fetal heart rate tracing, that is dose-dependent with increasing class of obesity. The investigators hypothesize that obese pregnant women and unfavorable cervix (Bishop score ≤ 6), IOL ≥ 24 weeks gestation using the Foley balloon plus vaginal misoprostol will result in reduced cesarean delivery rates when compared to vaginal misoprostol alone.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Primary location

The University of Texas Health Science Center

Houston, Texas, 77030, United States

About this study

Nulliparous pregnant women at ≥ 32 weeks' gestation admitted to labor and delivery for IOL and who meet the inclusion and exclusion criteria will be approached by the research staff. Group 1 will be composed of women allocated to the Foley balloon plus misoprostol. These women will receive vaginal misoprostol per standard protocol at 25 micrograms every 4 hours. In addition, a 26 Fr-Foley balloon catheter will be inserted by routine clinical standards. The Foley will be inserted through the internal cervical os, filled with 60 mL of normal saline, and then pulled snugly against the internal os. The catheter of the Foley will be taped to the patient's inner thigh under gentle traction. If the Foley is unable to be placed, the patient will be reexamined in 1 hour and placement will be reattempted if Bishop's score is still 6 or less by the healthcare provider. When the Foley balloon had fallen out or had to be removed because 12 hours have passed since insertion as per protocol, further management of labor will be left at the discretion of the labor team.

Group 2 will be composed of women allocated to vaginal misoprostol-only. These women will receive 25 micrograms of misoprostol per vagina every 4 hours. Once the cervix becomes favorable (Bishop score > 6), misoprostol administration will be discontinued. Similarly, further management will be left at the discretion of the labor team.

In both groups, if IV oxytocin is indicated, it will be withheld until 4 hours after the last dose of misoprostol to prevent uterine hyperstimulation. Other aspects of labor management will be similar for both groups, including continuous electronic fetal monitoring with external Doppler device or fetal scalp electrode. Uterine contraction assessment will be performed with either an external tocodynamometer or an intrauterine pressure catheter.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Nulliparous women aged 18 or above
  • BMI ≥ 30 at the time of labor induction
  • Singleton gestation
  • Cephalic presentation (includes successful external cephalic version)
  • Intact fetal membranes
  • Unfavorable cervix (Bishop score of ≤ 6)
  • Gestational age ≥ 32 weeks

Exclusion criteria

  • Patient not candidate for IOL with misoprostol as deemed by the treating physician
  • Multiple gestation
  • Major fetal anomalies
  • Fetal demise

Treatment and study plan

Vaginal Misoprostol

Drug

Other names: Cytotec

Foley Balloon + Vaginal Misoprostol

Device

Primary outcomes

  1. Number of Participants With a Need for Cesarean Delivery

    Time frame: Induction to delivery

Secondary outcomes

  1. Indication for Cesarean Delivery

    Time frame: Induction to delivery

    Categories of Indications for Cesarean Delivery:

    • = Cephalopelvic disproportion
    • = Failed induction/Failure to progress
    • = Cord prolapse
    • = Non-reassuring fetal tracing
    • = Malpresentation
    • = Placental abruption
    • = Other
  2. Induction-to-delivery Interval in Hours

    Time frame: Induction to delivery

  3. Number of Participants With a Need for Oxytocin Augmentation

    Time frame: Induction to delivery

  4. Number of Participants Exhibiting Tachysystole Resulting in Fetal Heart Rate Abnormalities

    Time frame: Induction to delivery

    Uterine tachysystole is a condition of excessively frequent uterine contractions during pregnancy. Tachysystole is indicated ≥ 5 contractions in a 10 minute period averaged over a 30-minute window.

  5. Number of Participants With Clinical Chorioamnionitis

    Time frame: Induction to delivery

    Clinical chorioamnionitis is indicated by maternal fever ≥ 100.4 Fahrenheit, uterine fundal tenderness, maternal or fetal tachycardia (>100/min and >160/min, respectively), and purulent or foul amniotic fluid.

  6. Number of Participants With a Need for Operative Vaginal Delivery

    Time frame: Induction to delivery

  7. Composite Maternal Morbidity as Indicated by the Number of Participants With Measures of Maternal Morbidity

    Time frame: Induction to discharge (approximately 5 days)

    Measures of maternal morbidity assessed:

    • Maternal ICU admission
    • Postpartum endometritis
    • Surgical-site infections prior to discharge
    • Venous thromboembolism
    • Need for transfusion
    • Maternal death
  8. Number of Newborns Admitted to the Neonatal Intensive Care Unit (NICU)

    Time frame: From delivery to neonatal discharge (approximately 2 to 7 days)

  9. Number of Newborns With Transient Tachypnea (TTN)

    Time frame: From delivery to neonatal discharge (approximately 2 to 7 days)

  10. Number of Newborns With Respiratory Distress Syndrome (RDS)

    Time frame: From delivery to neonatal discharge (approximately 2 to 7 days)

  11. Number of Newborns With Meconium Aspiration Syndrome

    Time frame: From delivery to neonatal discharge (approximately 2 to 7 days)

  12. Number of Newborns With Culture-proven Sepsis

    Time frame: From delivery to neonatal discharge (approximately 2 to 7 days)

  13. Number of Newborns With Seizures

    Time frame: From delivery to neonatal discharge (approximately 2 to 7 days)

  14. Composite Neonatal Morbidity as Indicated by the Number of Newborns With Measures of Neonatal Morbidity

    Time frame: From delivery to neonatal discharge (approximately 2 to 7 days)

    Measures of neonatal morbidity assessed:

    • Apgar score ≤ 7 at 5 mins
    • Umbilical cord potential of hydrogen (pH) < 7.1
    • Neonatal injury: brachial plexus injury, fracture
    • Perinatal death

Sponsors and collaborators

Lead sponsor

The University of Texas Health Science Center, Houston

Other

Registry information

Official study title

The Efficacy of Transcervical Foley Balloon Plus Vaginal Misoprostol Versus Vaginal Misoprostol Alone For Cervical Ripening In Nulliparous Obese Women: A Randomized, Comparative Effectiveness Trial

Acronym: CROWN

Important dates

Study start
2016
Primary completion
2018
Study completion
2018
First posted
Dec 24, 2015
Registry last updated
Aug 26, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.